Pharmaceutical information technology consultancy buys registration management tool from Phase Forward
Specialist pharmaceutical information technology consultancy Synapse Partnership has completed the prestigious acquisition of the RegTracker registration management tool from provider of data management solutions for clinical trials and drug safety, Phase Forward.
Synapse now holds responsibility for global marketing, sales, installation, development, support and maintenance of RegTracker.
Former Phase Forward employee Ola Strandberg has joined the team to ensure continuity of customer support, maintenance and development, and help facilitate a smooth transition between the two companies.
An established provider of both software product and development services and validation consultancy to the international pharmaceutical industry, Synapse has a strong regulatory compliance practice particularly focussed on FDA 21 CFR Part 11.
Managing director Adam Sherlock commented: "RegTracker is a perfect fit in our portfolio in terms of its scope, customer profile and market potential." Regtracker simplifies the logistics of keeping track of product registration and licensing on a worldwide basis, and provides critical product information to key decision-makers.
In addition to acting as a repository with reporting and publishing capabilities, it contains powerful search functionality for instant access to product registration information.
